Cargando…
Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903148/ https://www.ncbi.nlm.nih.gov/pubmed/36759050 http://dx.doi.org/10.1016/j.eimce.2022.04.014 |
| _version_ | 1784883417670746112 |
|---|---|
| author | Sánchez Fabra, David Herrero Jordán, Tina |
| author_facet | Sánchez Fabra, David Herrero Jordán, Tina |
| author_sort | Sánchez Fabra, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9903148 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99031482023-02-07 Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns Sánchez Fabra, David Herrero Jordán, Tina Enferm Infecc Microbiol Clin (Engl Ed) Scientific Letter Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023-02 2023-02-07 /pmc/articles/PMC9903148/ /pubmed/36759050 http://dx.doi.org/10.1016/j.eimce.2022.04.014 Text en © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Letter Sánchez Fabra, David Herrero Jordán, Tina Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns |
| title | Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns |
| title_full | Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns |
| title_fullStr | Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns |
| title_full_unstemmed | Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns |
| title_short | Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns |
| title_sort | generalized use of nirmatrelvir plus ritonavir (paxlovid): raising concerns |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903148/ https://www.ncbi.nlm.nih.gov/pubmed/36759050 http://dx.doi.org/10.1016/j.eimce.2022.04.014 |
| work_keys_str_mv | AT sanchezfabradavid generalizeduseofnirmatrelvirplusritonavirpaxlovidraisingconcerns AT herrerojordantina generalizeduseofnirmatrelvirplusritonavirpaxlovidraisingconcerns |